Find uplifting stories about heroes, innovations, and solutions
54 results for "glp-1"
Popular diabetes and weight loss medications may help fight addiction itself, silencing cravings across alcohol, nicotine, opioids, and other substances. A study of over 600,000 veterans shows these drugs could save lives in unexpected ways.
A groundbreaking study of 112,000 women found that those taking GLP-1 medications like Ozempic had up to 35% lower rates of breast cancer. While the research shows association rather than proof, doctors say the connection through weight loss and metabolic changes could reshape prevention strategies.
Popular weight-loss medications like Ozempic may dramatically slow the spread of certain cancers, according to groundbreaking research from Cleveland Clinic. The study found up to 50% lower progression rates for four major cancer types among patients taking these drugs.
NIH researchers have discovered why popular weight loss drugs like Ozempic eventually stop working as well, and they've found a potential way to extend their effectiveness. The breakthrough could help millions push past frustrating plateaus.
NIH researchers discovered why popular GLP-1 medications like Ozempic eventually stop working as well, and they found a possible solution. The breakthrough could help millions push past frustrating weight loss plateaus.
A five-year study of over 12,000 patients shows that GLP-1 drugs, commonly used for diabetes and weight loss, significantly reduced the spread of four major cancer types. The findings offer new hope for cancer patients, though experts urge caution before prescribing the medications specifically for cancer treatment.
Scientists discovered that popular weight loss medications like Wegovy might one day treat arthritis by fighting inflammation directly inside joints. This breakthrough could transform how millions manage painful joint conditions.
Diabetes medications like Ozempic and Wegovy may help stop cancer from spreading, according to groundbreaking research tracking over 10,000 cancer patients. The study found these drugs reduced the risk of cancer progression by up to 50% for certain tumor types.
Danish researchers found that popular GLP-1 drugs like semaglutide reduced asthma flare-ups by a quarter and cut inhaler dependence by 14%. The breakthrough suggests these medications do more than just help with weight loss.
New research shows that people who lost the most weight on GLP-1 medications like Ozempic dramatically reduced their risk of serious health problems. Those who shed at least 15% of their body weight saw sleep apnea risk drop by 69% and kidney disease risk fall by 30%.
Scientists have found two promising methods to help people maintain their weight loss after stopping diets or GLP-1 medications like Wegovy. New research shows a daily pill and a probiotic supplement can both help prevent the frustrating cycle of weight regain.
The diabetes and weight-loss medication semaglutide (Ozempic/Wegovy) just proved effective at treating alcohol-use disorder in a major clinical trial. Millions struggling with problem drinking now have a new treatment option their doctors already know how to prescribe.
New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.
Scientists created a "Trojan horse" drug that delivers double the weight loss power by sneaking extra metabolism boosters directly into cells. Early tests in mice showed stronger results than current treatments, with fewer side effects because it works only where needed.
A new study linking weight loss drugs to bone loss made headlines, but experts say the real story is far more hopeful. Simple steps like strength training and eating enough protein can protect your bones during weight loss.
A groundbreaking trial found that semaglutide, the popular weight loss drug, significantly reduced alcohol cravings and heavy drinking days in people battling both obesity and alcohol addiction. The discovery could transform treatment options for millions worldwide struggling with alcohol use disorder.
Semaglutide, the active ingredient in Ozempic and Wegovy, helped people with obesity reduce heavy drinking days by 41% in a groundbreaking six-month trial. This marks the first randomized study testing GLP-1 drugs for alcohol use disorder treatment.
Ozempic and similar medications may heal arthritis, liver disease, and more by resetting the immune system, not just through weight loss. Scientists are discovering these drugs work throughout the body to reduce harmful inflammation while keeping infection-fighting power strong.
Early research suggests GLP-1 drugs like Ozempic might help treat endometriosis, offering hope to millions who struggle with limited treatment options. Women are already reporting symptom improvements on social media.
Scientists discovered a naturally occurring hormone that triggers weight loss by speeding up metabolism instead of reducing appetite. Early studies show the hormone FGF21 works differently than popular GLP-1 drugs, offering new hope for obesity treatment.
Showing 20 of 54